Anna L. Peljto

2.6k total citations
14 papers, 736 citations indexed

About

Anna L. Peljto is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Anna L. Peljto has authored 14 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Anna L. Peljto's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Medical Imaging and Pathology Studies (5 papers) and Occupational and environmental lung diseases (3 papers). Anna L. Peljto is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Medical Imaging and Pathology Studies (5 papers) and Occupational and environmental lung diseases (3 papers). Anna L. Peljto collaborates with scholars based in United States, Italy and South Africa. Anna L. Peljto's co-authors include David A. Schwartz, Marvin I. Schwarz, Tasha E. Fingerlin, David A. Greenberg, Roberto Insolia, Lia Crotti, Althea Goosen, Paul A. Brink, Peter J. Schwartz and Alfred L. George and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Anna L. Peljto

14 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna L. Peljto United States 9 434 159 143 136 91 14 736
B. Schlüter Germany 13 76 0.2× 29 0.2× 120 0.8× 118 0.9× 13 0.1× 46 471
Constantine Farmakidis United States 10 52 0.1× 80 0.5× 23 0.2× 123 0.9× 67 0.7× 21 577
Kathleen Kelley United States 7 85 0.2× 22 0.1× 24 0.2× 76 0.6× 96 1.1× 12 382
Justin Kinsella Ireland 11 103 0.2× 103 0.6× 42 0.3× 102 0.8× 26 0.3× 23 366
Carin G. Faber Netherlands 7 199 0.5× 45 0.3× 301 2.1× 140 1.0× 20 0.2× 8 471
Salvatore Caputo Italy 12 168 0.4× 104 0.7× 19 0.1× 88 0.6× 16 0.2× 23 436
Lorena Benavente Spain 11 60 0.1× 57 0.4× 15 0.1× 48 0.4× 36 0.4× 50 363
Francesco Canonico Italy 10 36 0.1× 64 0.4× 46 0.3× 109 0.8× 19 0.2× 51 301
Athina Xaidara Greece 10 35 0.1× 14 0.1× 60 0.4× 121 0.9× 114 1.3× 21 355

Countries citing papers authored by Anna L. Peljto

Since Specialization
Citations

This map shows the geographic impact of Anna L. Peljto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Peljto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Peljto more than expected).

Fields of papers citing papers by Anna L. Peljto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Peljto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Peljto. The network helps show where Anna L. Peljto may publish in the future.

Co-authorship network of co-authors of Anna L. Peljto

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L. Peljto. A scholar is included among the top collaborators of Anna L. Peljto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L. Peljto. Anna L. Peljto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bridges, James P., Eszter K. Vladar, Jonathan S. Kurche, et al.. (2025). Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium. Journal of Clinical Investigation. 135(1). 8 indexed citations
2.
Blumhagen, Rachel Z., Stephen M. Humphries, Anna L. Peljto, et al.. (2024). MUC5B Genotype and Other Common Variants Are Associated with Computational Imaging Features of Usual Interstitial Pneumonia. Annals of the American Thoracic Society. 22(4). 533–540. 1 indexed citations
3.
Furusawa, Haruhiko, Anna L. Peljto, Avram Walts, et al.. (2022). Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis. Thorax. 77(5). 508–510. 24 indexed citations
4.
Furusawa, Haruhiko, Jonathan Cardwell, Anna L. Peljto, et al.. (2021). Common Idiopathic Pulmonary Fibrosis (IPF) Genetic Variants Are Associated with Chronic Hypersensitivity Pneumonitis (CHP). A3143–A3143. 2 indexed citations
5.
Chung, Jonathan H., Anna L. Peljto, Ashish Chawla, et al.. (2016). CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism. CHEST Journal. 149(5). 1215–1222. 18 indexed citations
6.
Chung, Jonathan H., Ashish Chawla, Anna L. Peljto, et al.. (2014). CT Scan Findings of Probable Usual Interstitial Pneumonitis Have a High Predictive Value for Histologic Usual Interstitial Pneumonitis. CHEST Journal. 147(2). 450–459. 120 indexed citations
7.
Peljto, Anna L., Moisés Selman, Dong Soon Kim, et al.. (2014). The MUC5B Promoter Polymorphism Is Associated With Idiopathic Pulmonary Fibrosis in a Mexican Cohort but Is Rare Among Asian Ancestries. CHEST Journal. 147(2). 460–464. 85 indexed citations
8.
Peljto, Anna L., Christie Barker‐Cummings, Vincent M. Vasoli, et al.. (2014). Familial risk of epilepsy: a population-based study. Brain. 137(3). 795–805. 118 indexed citations
9.
Borie, Raphaël, Bruno Crestani, Philippe Dieudé, et al.. (2013). The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population. PLoS ONE. 8(8). e70621–e70621. 121 indexed citations
10.
Peljto, Anna L., Mark P. Steele, Tasha E. Fingerlin, et al.. (2012). The Pulmonary Fibrosis-Associated MUC5B Promoter Polymorphism Does Not Influence the Development of Interstitial Pneumonia in Systemic Sclerosis. CHEST Journal. 142(6). 1584–1588. 54 indexed citations
11.
Cosgrove, Gregory P., Steve D. Groshong, Anna L. Peljto, et al.. (2012). The MUC5B Promoter Polymorphism Is Associated With A Less Severe Pathological Form Of Familial Interstitial Pneumonia (FIP). A6865–A6865. 6 indexed citations
12.
Stewart, William C., Anna L. Peljto, & David A. Greenberg. (2009). Multiple Subsampling of Dense SNP Data Localizes Disease Genes with Increased Precision. Human Heredity. 69(3). 152–159. 7 indexed citations
13.
Crotti, Lia, Maria Cristina Monti, Roberto Insolia, et al.. (2009). NOS1AP Is a Genetic Modifier of the Long-QT Syndrome. Circulation. 120(17). 1657–1663. 171 indexed citations
14.
Crotti, Lia, Roberto Insolia, Maria Cristina Monti, et al.. (2009). NOS1AP Is a Genetic Modifier of Congenital Long-QT Syndrome. Heart Rhythm. 6(11). 1695–1695. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026